Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.54 CNY -1.95% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Hunan Fangsheng Pharmaceutical Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hunan Fangsheng Pharmaceutical Co Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Deferred Income Tax
ÂĄ33.2m
CAGR 3-Years
18%
CAGR 5-Years
59%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Deferred Income Tax
ÂĄ255m
CAGR 3-Years
28%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Deferred Income Tax
ÂĄ22.5m
CAGR 3-Years
-23%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Deferred Income Tax
ÂĄ85.1m
CAGR 3-Years
65%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Deferred Income Tax
ÂĄ91.3m
CAGR 3-Years
18%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.6B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Deferred Income Tax?
Deferred Income Tax
33.2m CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Deferred Income Tax amounts to 33.2m CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
59%

Over the last year, the Deferred Income Tax growth was 9%. The average annual Deferred Income Tax growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 18% over the past three years , 59% over the past five years .

Back to Top